Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Profile
Experience
History
Clear Focus
Key Strengths
Track Record
Team
Investment Practice
Portfolio
FAQ
Download Area
News
Events
Contact Us
Text size

Clear focus

exclusive focus on the life sciences —
active early-stage investments —
strong track record

From its inception, GLSV has benefited from a clear focus by investing exclusively in the life sciences. The emphasis is on securing attractive investment opportunities through careful identification of companies offering superior technologies and customer benefit. Predominantly, investments have been made in early-stage innovative companies.

GLSV has invested in many enterprises committed to innovative science and technologies. The GLSV portfolio includes companies active in many areas of the life sciences including:

  • Cancer
  • Immunology
  • Vaccines
  • Biopharmaceuticals
  • Indication-specific genomics
  • Genomics tools
  • Diagnostics
  • Medical devices
  • Healthcare services
  • Cardiovascular

These companies are shaping the future direction of biological science and modern health care.

A list of some of our Portfolio Companies.